BRIEF published on 10/11/2024 at 18:21, 1 month 11 days ago Funding Circle Plc: Share Buyback Details London Stock Exchange Ordinary Shares Share Buyback Market Regulation Issuance Capital
PRESS RELEASE published on 10/11/2024 at 18:16, 1 month 11 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces purchase and cancellation of 80,896 ordinary shares at prices between 137.00p and 138.50p each London Stock Exchange Ordinary Shares Share Buyback Cancellation Funding Circle Plc
BRIEF published on 10/10/2024 at 18:22, 1 month 12 days ago Funding Circle Plc Completes Share Buyback London Stock Exchange Ordinary Shares Share Buyback FCA Regulations Funding Circle
PRESS RELEASE published on 10/10/2024 at 18:17, 1 month 12 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Holdings plc announces purchase of 125,000 ordinary shares for cancellation on the London Stock Exchange, part of buy-back program London Stock Exchange Buy-back Program Purchase Cancellation Funding Circle Holdings
BRIEF published on 10/09/2024 at 18:10, 1 month 13 days ago Funding Circle Plc: Share Buyback Update London Stock Exchange Share Buyback Market Regulation Funding Circle Stock Cancellation
PRESS RELEASE published on 10/09/2024 at 18:05, 1 month 13 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces purchase of 25,000 of its own shares at 134.00p each for cancellation, impacting its issued share capital London Stock Exchange Ordinary Shares Share Purchase Cancellation Funding Circle Plc
BRIEF published on 10/08/2024 at 18:13, 1 month 14 days ago Funding Circle Announces Share Buy-Back Completion Share Buy-back London Stock Exchange Ordinary Shares Market Regulation Funding Circle
PRESS RELEASE published on 10/08/2024 at 18:08, 1 month 14 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Holdings plc announces purchase of 67,228 ordinary shares for cancellation on London Stock Exchange at various prices. Company's issued share capital after cancellation: 334,545,574 shares with voting rights London Stock Exchange Ordinary Shares Purchase Cancellation Funding Circle Holdings PLC
BRIEF published on 10/07/2024 at 18:30, 1 month 15 days ago Funding Circle Plc Completes Share Buyback Transaction London Stock Exchange Share Buyback Numis Securities Market Regulation Funding Circle
PRESS RELEASE published on 10/07/2024 at 18:25, 1 month 15 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces purchase and cancellation of 138,239 ordinary shares at prices between 130.00p and 132.00p as part of buy-back program Ordinary Shares Buy-back Program Purchase Cancellation Funding Circle Plc
Published on 11/22/2024 at 23:55, 2 hours 54 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 3 hours 19 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 3 hours 44 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 4 hours 19 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 8 hours 34 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 8 hours 55 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 9 hours 53 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 10 hours 49 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 1 day 19 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 7 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 9 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 9 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
